4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-21-068013
Chief Executive Officer gave up 779 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2021-12-01 | Shares withheld for taxes | −779 | $75.10 | $58,503 | 219,153 | D |
Loading xslF345X03/doc4.xml…